Companies/US/ACH

ACCENDRA HEALTH, INC.

Income flow

Annual
ACH 10-K Income StatementPeriod 2025-12-31Source 10-K
Diabetes ProductUNIT_STA 783MSleep Therapy ProductUNIT_STA 740MHome Respiratory Therapy ProductUNIT_STA 433MProduct And Service OtherUNIT_STA 288MOstomyUNIT_STA 213MWound CareUNIT_STA 189MUrologyUNIT_STA 116MRevenueUNIT_STA 3B-74% Y/YGross profitUNIT_STA 1B-42% Y/YCost of revenueUNIT_STA 1BOperating profitUNIT_STA 27M+113% Y/YOperating expensesUNIT_STA 1BSG&AUNIT_STA 1BR&D & otherUNIT_STA 194M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · UNIT_STA
By activity
By activityUNIT_STA 2.8B
  • Diabetes ProductUNIT_STA 783M28.4%
  • Sleep Therapy ProductUNIT_STA 740M26.8%
  • Home Respiratory Therapy ProductUNIT_STA 433M15.7%
  • Product And Service OtherUNIT_STA 288M10.4%
  • OstomyUNIT_STA 213M7.7%
  • Wound CareUNIT_STA 189M6.8%
  • UrologyUNIT_STA 116M4.2%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.4.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).76.9MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).56.2M
Dividend calendar
Ex-dividend
2021-12-14
Pay date
2021-12-31
Last cash
0.003 · 2021-12-14
Stock splits
  1. 3:22010-04-01